Emisphere Shareholder Wants Out Of $32M Class Settlement

A major shareholder of Emisphere Technologies has objected to a proposed $32 million settlement in a suit challenging the $1.8 billion sale of the biotechnology company to Novo Nordisk A/S, arguing that...

Already a subscriber? Click here to view full article